Fig. 5From: In vivo degradation and neovascularization of silk fibroin implants monitored by multiple modes ultrasound for surgical applicationsSilk fibroin implants at the upper back subcutaneous at day 0, 4, 8, 12, and 16 (a–e) observed by 4D View softwareBack to article page